Skip to main content
Premium Trial:

Request an Annual Quote

Oh, You Do It

This post has been changed due to an update to the Technology Review article.

Technology Review focuses its attention on RainDance Technologies' droplet-based microfluidics system, saying it "can be adapted to perform a number of chemical analyses." The company itself, though, is not developing its own genetic diagnostics, Tech Review says, but is selling its technology to labs that do. Emory's Madhuri Hegde is using the technology to develop a test for an X-linked form of mental retardation that looks at 93 different genes. "I think [the RainDance technology] holds lots of promise in a clinical setting," Hegde says, though she notes that it is expensive.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.